Sandy Macrae is the founder of Sangamo Therapeutics. Sangamo Therapeutics has raised $1.5B in total funding. Based in Richmond, California, United States.
Sandy Macrae is the Chief Executive Officer of Sangamo Therapeutics, a biotechnology company focused on gene editing and zinc finger technologies. He has been with Sangamo since June 2016 and has raised over USD 1.5 billion in total funding, including USD 800 million from partnerships.
Full founder directory · Investor directory · Company funding database · Fundraising library